What is Wedbush’s Estimate for Geron FY2029 Earnings?
Geron Co. (NASDAQ:GERN – Free Report) – Analysts at Wedbush issued their FY2029 EPS estimates for shares of Geron in a research report issued on Monday, April 21st. Wedbush analyst R. Driscoll forecasts that the biopharmaceutical company will earn $0.96 per share for the year. The consensus estimate for Geron’s current full-year earnings is ($0.25) […]
Geron Co. (NASDAQ:GERN – Free Report) – Analysts at Wedbush issued their FY2029 EPS estimates for shares of Geron in a research report issued on Monday, April 21st. Wedbush analyst R. Driscoll forecasts that the biopharmaceutical company will earn $0.96 per share for the year. The consensus estimate for Geron’s current full-year earnings is ($0.25) […]